3 documents found, page 1 of 1
The HepHIV 2023 Madrid conference: A call to action for political leadership in...
Simões, D; Raben, D; Moran, AB; Imaz, A; Stengaard, AR; Raahauge, A; Sullivan, AK; Vaughan, E; Brännström, J; De Baetselier, I; Platteau, T; Casabona, JIntroduction and Objectives: The HepHIV 2023 Conference, held in Madrid in November 2023, highlighted how Europe is not on track to meet the United Nations (UN) sustainable development goals and Joint UN Programme on HIV/AIDS (UNAIDS) targets. This article presents the outcomes of the conference, which focus on ways to improve testing and linkage to care for HIV, viral hepatitis, and other sexually transmitted ...
Late diagnosis of HIV: An updated consensus definition
Croxford, S; Stengaard, AR; Brännström, J; Combs, L; Dedes, N; Girardi, E; Grabar, S; Kirk, O; Kuchukhidze, G; Lazarus, JV; Noori, T; Pharris, AIntroduction: In recent years, HIV testing frequency has increased, resulting in more people being diagnosed during seroconversion with a temporarily low CD4 count. Using the current consensus definition of late HIV presentation ('presenting for care with a CD4 count < 350 cells/μL or an AIDS-defining event, regardless of CD4 count') these individuals would be incorrectly assigned as being diagnosed late. Metho...
The Association Between Hepatitis B Virus Infection and Nonliver Malignancies i...
Mocroft, A; Miro, J; Wandeler, G; Llibre, J; Boyd, A; van Bremen, K; Beniowski, M; Mikhalik, J; Cavassini, M; Maltez, F; Duvivier, C; Uberti Foppa, CObjectives: The aim of this study was to assess the impact of hepatitis B virus (HBV) infection on non-liver malignancies in people living with HIV (PLWH). Methods: All persons aged ≥ 18 years with known hepatitis B virus (HBV) surface antigen (HBsAg) status after the latest of 1 January 2001 and enrolment in the EuroSIDA cohort (baseline) were included in the study; persons were categorized as HBV positive or ...